Citations

Clear

2960 citation(s) found for "Kim, P".

Genetic Alterations in Olfactory Neuroblastoma: Insights from the AACR Genie Database
Hsia, Beau, Bitar, Gabriel , Alshaka, Saif, Levy, Danielle, Crawford, John, Hsia, Beau , Valencia, Bastien A. , Levy, Michael L. , Sato, Mariko , Faraji, Farhoud , Kim, Jeeho D. , Polster, Sean P. , Patel, Vijay A.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803168 Get It

Comprehensive Genomic Profiling of Sinonasal Carcinomas: Identification of Common Mutations and Potential Targets for Therapy
Bitar, Gabriel , Hsia, Beau, Alshaka, Saif, Crawford, John, Levy, Danielle, Hsia, Beau , Sato, Mariko , Levy, Michael L. , Valencia, Bastien A. , Kim, Jeeho D. , Faraji, Farhoud , Polster, Sean P. , Patel, Vijay A.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803103 Get It

Genomic Characterization of Chordomas: Insights from a National Database
Hsia, Beau, Alshaka, Saif, Bitar, Gabriel , Levy, Danielle, Crawford, John, Hsia, Beau , Faraji, Farhoud , Kim, Jeeho D. , Valencia, Bastien A. , Levy, Michael L. , Sato, Mariko , Polster, Sean P. , Patel, Vijay A.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803071 Get It

A Multicenter Comparison of CRH versus DDAVP Stimulation Responses in Inferior Petrosal Sinus Sampling for Cushing’s Disease
Karsy, Michael, Silverstein, Julie , Evans, James J., Collopy, Sarah , Kelly, Dan, Fernandez‐Miranda, Juan C. , Pacione, Donato , Bergsneider, Marvin , Zada, Gabriel , Kshettry, Varun R. , Wu, Kyle C., Benjamin, Carolina , Catalino, Michael P. , Zwagerman, Nathan T. , Little, Andrew S. , Yuen, Kevin Choong Ji, ITorok, Ildiko, Gardner, Paul A. , Karsy, Michael , Karsy, Michael , Kim, Albert Sungsoo , Rennert, Robert C , Couldwell, William T. , Barkhoudarian, Garni , Kim, Won Bae , Chicoine, Michael , Gompel, Jamie J. Van , Mamelak, Adam N. , Yuen, Kevin C.J.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803037 Get It

Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus
Cancer, Expert Panel Management of Cervical Esophageal, Williams, Vonetta M. , Hallemeier, Christopher L. , Shah, Pari , Anker, Christopher J. , Abood, Gerard, Akselrod, Dmitriy , Kennedy, Timothy J., Lee, Percy, Sharma, Navesh , William, Small, Russo, Suzanne , Russo, Suzanne , Cancer, Expert Panel Management of Cervical Esophageal, Hallemeier, Christopher Leigh , Jethwa, Krishan R. , Selfridge, Jennifer Eva , Berlin, Jordan D. , Kim, Ed, Lee, Percy , William, Small, Tchelebi, Leila T.

Mayo Clinic

American Journal of Clinical Oncology | February 6, 2025 | Volume: 48 | Issue: 4 | Pages: 163-179

10.1097/coc.0000000000001165 | PMID 39912327 Get It

Objectives: Cervical esophageal cancer (CEC) is an uncommon malignancy accounting for <5% of all esophageal carcinomas. Treatment of CEC varies and is adapted from established regimens used for squamous cell carcinoma (SCC) or the lower esophageal and head and neck. The present systematic review and guidelines are intended to assist treatment decision making for patients with CEC based on the available evidence. Methods: Using the Population, Intervention, Comparator, Outcome, Timing, and Study Design (PICOTS) framework, the evidence regarding treatment outcomes was assessed using Cochrane and PRISMA 2020 methodology. Eligible studies included prospective Phase II to III trials and retrospective analyses published between January 1, 2013 and February 23, 2024 in the Ovid Medline database. These references were assessed through the American Radium Society (ARS) Appropriate Use Criteria (AUC) methodology. A systematic review PRISMA 2020 checklist confirmed the completion of essential elements. RAND-UCLA consensus methodology was used by the expert panel to rate the appropriateness of the treatment options. Results: ARS AUC recommendations include (1) larynx preservation using endoscopic resection (EMR or ESD) alone for the typical case with pT1a cN0 cM0 CEC, (2) definitive CRT for the typical case with cT1bN0M0 in patients who cannot undergo endoscopic resection, (3) larynx-preserving using definitive CRT (with or without induction chemotherapy) for the typical case with nonmetastatic locally advanced CEC (advanced T-stage tumors or involved lymph nodes), with surgery reserved for those patients with incomplete response or locoregional recurrence. Conclusions: This ARS AUC summary provides guidelines for the management of SCC of the cervical esophagus provides based on available evidence. Topics that warrant further investigation include optimization of (1) patient selection; (2) multimodality therapies including chemotherapy, immunotherapy, and targeted agents; (3) radiation dose, schedule, and treatment volume; and (4) supportive care for patients with CEC. Ongoing trials continue to improve outcomes for patients with CEC.
Genomic Characterization of Chordoma: Insights from the AACR Project GENIE Database
Hsia, Beau, Bitar, Gabriel , Alshaka, Saif, Kim, Jeeho D. , Valencia‐Sanchez, Bastien A. , Brandel, Michael G. , Sato, Mariko , Levy, Michael L. , Patel, Vijay A. , Polster, Sean P. , Brandel, Michael G , Sato, Mariko , Patel, Vijay A , Polster, Sean P , Hsia, Beau , Faraji, Farhoud , Crawford, John Ross

Mayo Clinic

Cancers | February 5, 2025 | Volume: 17 | Issue: 3 | Pages: 536

10.3390/cancers17030536 | PMID 39941902 Get It

Background: Chordoma is a rare primary tumor originating from embryonic notochord remnants, with limited systemic therapeutic options due to a poor understanding of its genomic landscape. This study aims to characterize the genetic alterations in chordoma using a large national patient-level genomic repository, the AACR Project GENIE, to identify potential therapeutic targets and improve disease modeling. Methods: A retrospective analysis of chordoma samples was conducted using the AACR Project GENIE database. Targeted sequencing data were analyzed for recurrent somatic mutations, tumor mutational burden, and chromosomal copy number variations, with significance set at p < 0.05. Results: Frequent mutations were observed in genes associated with SWI/SNF complex affecting chromatin remodeling (SETD2, PBRM1, ARID1A). Mutations were also common among the TERT promoter regions, and cell cycle regulation (CDKN2A). Significant co-occurrences were identified among PBRM1, BRCA2, and KMT2D mutations. CDKN2A/B deletions were enriched in metastatic tumors, and pediatric cases demonstrated distinct mutation profiles compared to adults. Conclusions: This study provides a genomic profile of chordoma, identifying key mutations and potential therapeutic targets. These findings highlight the roles of chromatin remodeling and cell cycle pathways in chordoma biology, offering insights for future precision medicine approaches and therapeutic interventions.
Aerosol Generation During Spirometry and Simulated Bronchodilator Challenge Testing in the Pulmonary Function Laboratory
Gmehlin, Cameron G., Sajgalik, Pavol , Hainy, Matthew E, Kim, Chul‐Ho , Johnson, Bruce D. , Allison, Thomas G. , Gmehlin, Cameron G. , Lim, Kaiser, Lim, Kaiser G. , Niven, Alexander S.

Mayo Clinic

Respiratory Care | February 3, 2025 | Volume: 70 | Issue: 4 | Pages: 446-449

10.1089/respcare.12506 | PMID 39969939 Get It